Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
224.4 USD | -0.26% |
|
-1.76% | -13.04% |
07-16 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
07-16 | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 32.76B | |
+7.46% | 100B | |
+8.42% | 42.34B | |
+80.04% | 29.46B | |
-10.92% | 16.31B | |
+1.93% | 14.39B | |
-6.77% | 12.23B | |
+177.16% | 10.47B | |
-0.37% | 8.97B | |
-56.13% | 8.84B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Inc., Q4 2016 Earnings Call, Jan 26, 2017